In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at ...
The federal government is suing three big pharmacy benefit managers (PBMs) over a system of drug rebates that regulators say ...
The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The Federal Trade Commission has accused three major pharmacy benefit managers of inflating insulin prices, the agency said ...
The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...
The FTC says three companies that process about 80% of prescriptions in the United States have engaged in anticompetitive ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
The Federal Trade Commission sued the drug middlemen that health plans use to keep a lid on drug spending, accusing the firms ...
The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...
Regulators say the nation's largest pharmacy benefit managers are partly to blame for the soaring cost of insulin in the U.S.
UnitedHealth Group division calls the action “baseless” and shows “profound misunderstanding” of drug pricing.
The three PBMs have criticized the FTC’s approach to the industry, accusing it of bias. Express Scripts sued the FTC earlier this week seeking to force it to withdraw a report that said PBMs enrich ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback